Dragon Life Science Holdings Group, Inc. Logo

Dragon Life Science Holdings Group, Inc.

NOHO

(0.8)
Stock Price

0,00 USD

0% ROA

0% ROE

0x PER

Market Cap.

746.992,00 USD

0% DER

0% Yield

0% NPM

Dragon Life Science Holdings Group, Inc. Stock Analysis

Dragon Life Science Holdings Group, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Dragon Life Science Holdings Group, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

2 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

3 ROE

The stock's ROE indicates a negative return (-697.78%) on shareholders' equity, suggesting poor financial performance.

4 ROA

The stock's ROA (-42.62%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 DER

The stock is burdened with a heavy load of debt (264%), making it financially unstable and potentially risky for investors.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Dragon Life Science Holdings Group, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Dragon Life Science Holdings Group, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Dragon Life Science Holdings Group, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Dragon Life Science Holdings Group, Inc. Revenue
Year Revenue Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 258.521 100%
2014 588.864 56.1%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 7.336 100%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Dragon Life Science Holdings Group, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 20.312 100%
2012 0 0%
2013 0 0%
2014 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Dragon Life Science Holdings Group, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 42.176
2007 44.384 4.97%
2008 54.961 19.24%
2009 0 0%
2010 22.365 100%
2011 1.578.871 98.58%
2012 5.370.002 70.6%
2013 642.456 -735.86%
2014 717.936 10.51%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Dragon Life Science Holdings Group, Inc. EBITDA
Year EBITDA Growth
2006 -42.176
2007 -52.973 20.38%
2008 -54.961 3.62%
2009 -30.027 -83.04%
2010 -22.365 -34.26%
2011 -1.471.733 98.48%
2012 -4.362.563 66.26%
2013 -476.325 -815.88%
2014 -188.532 -152.65%
2016 -208.940 9.77%
2017 -360 -57938.89%
2018 -3.750 90.4%
2019 -1.530 -145.1%
2020 -1.430 -6.99%
2021 -213.150 99.33%
2022 0 0%
2023 -548.840 100%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Dragon Life Science Holdings Group, Inc. Gross Profit
Year Gross Profit Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 198.809 100%
2014 528.980 62.42%
2016 0 0%
2017 -5.000 100%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 100 100%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Dragon Life Science Holdings Group, Inc. Net Profit
Year Net Profit Growth
2006 -44.122
2007 -37.672 -17.12%
2008 -55.238 31.8%
2009 -30.027 -83.96%
2010 -22.365 -34.26%
2011 -2.534.520 99.12%
2012 -6.427.618 60.57%
2013 -731.066 -779.21%
2014 -9.421.692 92.24%
2016 -272.265 -3360.49%
2017 -215.748 -26.2%
2018 -3.748 -5657.89%
2019 -140.420 97.33%
2020 -44.251 -217.33%
2021 -264.195 83.25%
2022 0 0%
2023 -1.091.704 100%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Dragon Life Science Holdings Group, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 -1 0%
2012 0 0%
2013 0 0%
2014 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Dragon Life Science Holdings Group, Inc. Free Cashflow
Year Free Cashflow Growth
2006 -22.442
2007 -40.515 44.61%
2008 -36.305 -11.6%
2009 -13.182 -175.41%
2010 -7.303 -80.5%
2011 -518.513 98.59%
2012 -763.291 32.07%
2013 -395.903 -92.8%
2014 14.197 2888.64%
2016 -207.500 106.84%
2019 0 0%
2020 -1.428 100%
2021 -19.031 92.5%
2022 0 0%
2023 278 100%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Dragon Life Science Holdings Group, Inc. Operating Cashflow
Year Operating Cashflow Growth
2006 -22.442
2007 -40.515 44.61%
2008 -31.305 -29.42%
2009 -13.182 -137.48%
2010 -7.303 -80.5%
2011 -475.288 98.46%
2012 -761.171 37.56%
2013 -395.903 -92.26%
2014 14.197 2888.64%
2016 -207.500 106.84%
2019 0 0%
2020 -1.428 100%
2021 -19.031 92.5%
2022 0 0%
2023 278 100%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Dragon Life Science Holdings Group, Inc. Capital Expenditure
Year Capital Expenditure Growth
2006 0
2007 0 0%
2008 5.000 100%
2009 0 0%
2010 0 0%
2011 43.225 100%
2012 2.120 -1938.92%
2013 0 0%
2014 0 0%
2016 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Dragon Life Science Holdings Group, Inc. Equity
Year Equity Growth
2006 -106.529
2007 -81.601 -30.55%
2008 -124.239 34.32%
2009 -146.666 15.29%
2010 -156.431 6.24%
2011 -3.100.855 94.96%
2012 -144.697 -2043%
2013 354.237 140.85%
2014 -2.796.695 112.67%
2016 -925.816 -202.08%
2017 -1.091.351 15.17%
2018 -452.866 -140.99%
2019 -593.286 23.67%
2020 -637.537 6.94%
2021 -739.292 13.76%
2022 0 0%
2023 -2.216.478 100%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Dragon Life Science Holdings Group, Inc. Assets
Year Assets Growth
2006 0
2007 26.275 100%
2008 6.946 -278.28%
2009 2.621 -165.01%
2010 1.015 -158.23%
2011 421.535 99.76%
2012 99.455 -323.84%
2013 1.715.160 94.2%
2014 1.218.124 -40.8%
2016 5.000 -24262.48%
2017 10.000 50%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Dragon Life Science Holdings Group, Inc. Liabilities
Year Liabilities Growth
2006 106.529
2007 107.876 1.25%
2008 131.185 17.77%
2009 149.287 12.13%
2010 157.446 5.18%
2011 3.522.390 95.53%
2012 244.152 -1342.7%
2013 1.360.923 82.06%
2014 4.014.819 66.1%
2016 930.816 -331.32%
2017 1.101.351 15.48%
2018 452.866 -143.2%
2019 593.286 23.67%
2020 637.537 6.94%
2021 739.292 13.76%
2022 0 0%
2023 2.216.478 100%

Dragon Life Science Holdings Group, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0
Price to Earning Ratio
0x
Price To Sales Ratio
0x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
0
EV to Sales
0
EV Over EBITDA
0
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
0
FreeCashFlow Yield
0
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0
Graham NetNet
0

Income Statement Metrics

Net Income per Share
0
Income Quality
0
ROE
0
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0
EBT Per Ebit
0
Ebit per Revenue
0
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0
Return on Tangible Assets
0
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0
Current Ratio
0
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Dragon Life Science Holdings Group, Inc. Dividends
Year Dividends Growth

Dragon Life Science Holdings Group, Inc. Profile

About Dragon Life Science Holdings Group, Inc.

Dragon Life Science Holdings Group, Inc. operates as regional Internet service provider. The company offers Internet access, emails, and related services in the United States. It also provides administrative services; and focuses on teaching children Spanish through learning centers and various after school enrichment programs. The company was founded in 1998 and is headquartered in New York, New York.

CEO
Mr. Michael J. Gelmon LL.B.
Employee
0
Address
14 Wall Street
New York, 10005

Dragon Life Science Holdings Group, Inc. Executives & BODs

Dragon Life Science Holdings Group, Inc. Executives & BODs
# Name Age
1 Mr. Chis Lobato
Vice President of Sales
70
2 Mr. John Burke
Consulting Principal Accounting Officer & Principal Accountant
70
3 Mr. Michael J. Gelmon LL.B.
Chief Executive Officer & President
70
4 Mr. Jeff Mack
Vice President of Marketing
70
5 Mr. Luis Rodriguez
Chief Operating Officer
70
6 Mr. David R. Mayeux
Director of Corporate Development
70

Dragon Life Science Holdings Group, Inc. Competitors